Procaine Raw Material Powder For Local Anesthetics CAS:59-46-1
In the vast landscape of pharmaceutical compounds, procaine hydrochloride raw material powder stands as a historic and foundational pillar of local anesthesia. This fine, white, crystalline powder is not merely a chemical; it is the active pharmaceutical ingredient (API) that gave birth to the era of safe, synthetic local anesthetics. While newer agents have since been developed, procaine remains a subject of study and a tool in specific medical contexts. Its story is one of chemical innovation, physiological interaction, and enduring utility. This analysis delves into the essence of procaine powder, exploring its characteristics, mechanisms, applications, and pharmacokinetics with a focus on its role as a raw material for formulation.
What is Procaine Raw Material Powder?
Procaine, chemically known as 2-diethylaminoethyl-4-aminobenzoate hydrochloride, is an ester-type local anesthetic. In its raw material form, it is a white, odorless, crystalline powder that is highly soluble in water and alcohol but unstable in alkaline solutions. This powder is the purified, bulk substance used by pharmaceutical manufacturers to produce various medicinal formulations, most notably injectable solutions.
Its historical significance cannot be overstated. Synthesized in 1905 by Alfred Einhorn, procaine, marketed under the trade name Novocain, was the first widely used synthetic local anesthetic. It represented a monumental leap forward from the highly toxic cocaine, offering a much-improved safety profile and ushering in a new age of outpatient and surgical procedures.
Key Features and Properties
The features of procaine powder are defined by its chemical structure and inherent properties, which directly dictate its handling, formulation, and clinical behavior:
1.Ester Linkage: As an ester, its metabolic pathway is primarily hydrolysis by plasma pseudocholinesterase. This is a critical differentiator from amide-type anesthetics (like lidocaine) which are metabolized in the liver.
2.Vasodilatory Effect: A pronounced characteristic of procaine is its tendency to cause vasodilation (widening of blood vessels) at the site of injection. This property accelerates its absorption into the bloodstream, shortening its duration of action and potentially increasing systemic exposure.
3.pKa Value: Procaine has a pKa of approximately 8.9. This means a significant portion of the molecules is ionized (positively charged) at physiological pH (7.4). The ionized form binds to the sodium channels inside nerve axons to inhibit conduction, but the uncharged, lipid-soluble form is necessary to cross the lipid nerve membrane. The high pKa results in a slower onset of action compared to anesthetics with a pKa closer to 7.4.
4.Stability: The ester bond is susceptible to hydrolysis, especially in alkaline conditions or upon autoclaving (steam sterilization). This necessitates careful pH adjustment during the formulation of injectable solutions to ensure stability and shelf life.
5.Purity: Pharmaceutical-grade raw material powder must meet stringent compendial standards (e.g., USP, Ph. Eur.) for identity, assay, related substances, residual solvents, and microbial limits to ensure patient safety and efficacy.
Applications and Formulations
The primary application of procaine raw material powder is in the manufacture of injectable local anesthetics. Its uses, though more niche today, include:
●Infiltration Anesthesia: The injection of small amounts of procaine solution directly into the tissue to numb a small area, for example, for suturing minor lacerations.
●Nerve Blocks: Peripheral nerve blocks involve injecting the solution near a specific nerve or bundle of nerves to anesthetize a larger area, such as a finger, toe, or tooth (dental anesthesia). Its use in dentistry, while largely superseded by agents like lidocaine and articaine, was its original claim to fame.
●Spinal Anesthesia (Less Common): Historically, procaine was used in low spinal anesthesia for short-duration procedures below the waist. However, its shorter duration and higher incidence of side effects like hypotension have led to its replacement by other agents like bupivacaine for this purpose.
●Intravenous Regional Anesthesia (Bier Block): This technique involves intravenous injection of a local anesthetic into a tourniquet-isolated limb. Procaine can be used for this, but its ester nature and associated allergenic potential make it less ideal.
●Therapeutic Neural Therapy: In some complementary medicine practices, particularly in Europe, highly diluted procaine is used in "neural therapy" injections aimed at treating chronic pain and regulating the autonomic nervous system. This is a specialized and controversial application.
The raw powder is formulated into sterile, isotonic, aqueous solutions, typically at concentrations ranging from 1% to 2%. These solutions are often adjusted to a slightly acidic pH (around 4.0-4.5) to maintain stability and are packaged in single-use ampules or vials.
Benefits and Advantages
Procaine's benefits are contextual, often viewed through a historical lens or in comparison to its predecessor, cocaine:
●High Safety Margin: Its most significant benefit was its vastly superior safety profile compared to cocaine. It is not addictive and does not produce the central nervous system stimulation or cardiovascular toxicity associated with cocaine.
●Rapid Metabolism: Hydrolysis by ubiquitous plasma esterases means it has a very short plasma half-life (see below), reducing the risk of systemic toxicity if accidentally injected intravascularly.
●Low Tissue Toxicity: When injected correctly, procaine has minimal irritating effects on local tissues, making it suitable for infiltration.
●Cost-Effectiveness: As a long-established, off-patent molecule, the raw material is relatively inexpensive to produce.
Dosage, Cycle, and Pharmacokinetics
The handling of procaine raw material and the dosing of its final formulations are precise scientific endeavors.
Dosage:
Dosage is highly variable and is not a property of the raw powder itself but of the final formulated product. It is determined by the procedure, the area to be anesthetized, vascularity of the tissue, and patient factors (weight, health status). For infiltration and nerve blocks, typical doses range from 50 mg to a maximum of 500 mg for a healthy adult (using a 1% or 2% solution). The maximum recommended dose is 6-7 mg/kg of body weight, with or without a vasoconstrictor.
The "Cycle" (Onset, Duration, Offset):
The clinical cycle of action is a direct result of procaine's physicochemical properties:
●Onset of Action: Relatively slow (5-10 minutes) due to its high pKa, which limits the amount of lipid-soluble, membrane-penetrating base form available at tissue pH.
●Peak Effect: Achieved within 10-20 minutes post-injection.
●Duration of Action: Short, typically 30-60 minutes. This short duration is primarily due to its potent vasodilatory effect, which promotes rapid vascular absorption and removal from the injection site. The addition of a vasoconstrictor like epinephrine (often at a concentration of 1:200,000) can significantly prolong the duration (up to 90-120 minutes) by reducing local blood flow and systemic absorption.
Half-Life:
The half-life of a drug is a pharmacokinetic parameter describing the time it takes for the plasma concentration to reduce by half. Procaine has an exceptionally short distribution half-life (alpha half-life) of less than a minute due to its rapid distribution into tissues and even more rapid hydrolysis. Its elimination half-life (beta half-life) is approximately 30-60 seconds. This remarkably short half-life is attributable to its metabolism by pseudocholinesterase in the plasma and liver. The primary metabolite is para-aminobenzoic acid (PABA), which is excreted renally, and diethylaminoethanol. The PABA metabolite is significant as it is associated with allergic reactions in some individuals.
Clinical Data
|
Trade names |
Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester; 4-aminobenzoic acid 2-diethylaminoethyl ester; PROCAINE; novocaine |
|
CAS |
59-46-1 |
|
Molar mass |
236.315 |
|
MF |
C13H20N2O2 |
|
Purity |
Above 99% |
|
Apprarance |
White Crystalline Powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion: A Legacy Etched in Powder
Procaine raw material powder is far more than a historical artifact. It is the physical embodiment of a therapeutic revolution. While its clinical use has diminished in favor of amide anesthetics with faster onsets, longer durations, and lower allergenic potential, its role is secure. It serves as a critical teaching tool for understanding the structure-activity relationships of local anesthetics, a benchmark in pharmaceutical history, and a reminder of the constant evolution of medical science. The precise, white crystals of procaine hydrochloride continue to be a testament to the power of chemical synthesis to create safer, more effective tools for healing and pain relief. Its story, from raw powder to profound medical impact, remains a foundational chapter in the ongoing narrative of anesthesiology.
Hot Tags: procaine raw material powder for local anesthetics cas:59-46-1, China procaine raw material powder for local anesthetics cas:59-46-1 manufacturers, suppliers, factory, Agonist of the androgen receptor Methandienone, Anabolic Esters Boldenone Cypionate, Boldenone Cypionate, Cialis Treating Erectile Dysfunction, Exemestane, Steroid Raw Powders Injectables
